Cargando…
P-aminosalicylate metabolism in cancer patients sensitive and resistant to chemotherapy.
A reduced response of a tumour to chemotherapy may be due to the host's drug metabolism. To test this hypothesis, we measured the metabolism of a model drug, para-aminosalicylate (PAS). Volunteers and cancer patients ingested a single oral dose (2 g) of PAS and we measured the plasma disappeara...
Autores principales: | Lavigne, J. G., Barry, A., d'Auteuil, C., Delage, J. M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1977
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2025501/ https://www.ncbi.nlm.nih.gov/pubmed/577182 |
Ejemplares similares
-
Increase in the gastrointestinal absorption and in tissue storage of cyclophosphamide in L-1210 leukaemic mice at an advanced stage of the disease.
por: Lavigne, J. G., et al.
Publicado: (1975) -
p-Aminosalicylic Acid (P.A.S.)
por: Spring, F. S.
Publicado: (1949) -
Self-Assembling Polymers with p-Aminosalicylate Anions Supported by Encapsulation of p-Aminosalicylate for the Improvement of Drug Content and Release Efficiency
por: Keihankhadiv, Shadi, et al.
Publicado: (2023) -
Para-Aminosalicylic Acid: Pas
Publicado: (1950) -
Smartphone Screen Integrated Optical Breathalyzer
por: Lapointe, Jerome, et al.
Publicado: (2021)